MCID: PNL014
MIFTS: 45

Pineal Gland Cancer

Categories: Cancer diseases, Endocrine diseases

Aliases & Classifications for Pineal Gland Cancer

MalaCards integrated aliases for Pineal Gland Cancer:

Name: Pineal Gland Cancer 12 15
Tumor of the Pineal Region 12 73
Pinealoma 12 76
Malignant Neoplasm of Pineal Gland 73
Malignant Tumor of Pineal Gland 12
Malignant Pineal Region Tumor 12
Neoplasm of the Pineal Region 12
Neoplasm of Pineal Gland 12
Pineal Gland Neoplasm 73
Pineal Body Neoplasm 12
Pineocytic Tumor 12
Pineocytoma 73

Classifications:



External Ids:

Disease Ontology 12 DOID:5032
ICD10 33 C75.3
ICD9CM 35 194.4
MeSH 44 D010871

Summaries for Pineal Gland Cancer

Disease Ontology : 12 An endocrine gland located in the pineal gland located in the brain.

MalaCards based summary : Pineal Gland Cancer, also known as tumor of the pineal region, is related to papillary tumor of the pineal region and pineoblastoma. An important gene associated with Pineal Gland Cancer is TUBB3 (Tubulin Beta 3 Class III), and among its related pathways/superpathways are Neuroscience and Cytoskeleton remodeling Neurofilaments. The drugs Etoposide and Carboplatin have been mentioned in the context of this disorder. Affiliated tissues include the pineal gl, pineal and brain, and related phenotype is nervous system.

Wikipedia : 76 A pinealoma is a tumor of the pineal gland, a part of the brain that produces melatonin. If a pinealoma... more...

Related Diseases for Pineal Gland Cancer

Diseases related to Pineal Gland Cancer via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 157)
# Related Disease Score Top Affiliating Genes
1 papillary tumor of the pineal region 34.7 ENO2 SYP
2 pineoblastoma 28.9 ASMT DICER1 GFAP SAG SYP
3 pineocytoma 28.4 ASMT ENO2 GFAP SAG SYP TUBB3
4 ureter small cell carcinoma 10.5 ENO2 SYP
5 malignant sertoli cell tumor 10.5 ENO2 SYP
6 urinary bladder small cell neuroendocrine carcinoma 10.5 ENO2 SYP
7 auditory system cancer 10.5 ENO2 SYP
8 sinonasal undifferentiated carcinoma 10.5 ENO2 SYP
9 sensory organ benign neoplasm 10.5 ENO2 SYP
10 gallbladder small cell carcinoma 10.5 ENO2 SYP
11 pancreatic somatostatinoma 10.5 ENO2 SYP
12 cutaneous ganglioneuroma 10.5 ENO2 SYP
13 extrahepatic bile duct adenocarcinoma 10.5 ENO2 SYP
14 small cell carcinoma of the bladder 10.5 ENO2 SYP
15 chondroid chordoma 10.5 ENO2 TUBB3
16 orbital cancer 10.5 ENO2 SYP
17 middle ear adenoma 10.5 ENO2 SYP
18 pulmonary large cell neuroendocrine carcinoma 10.5 ENO2 SYP
19 atypical follicular adenoma 10.5 ENO2 SYP
20 cerebellum cancer 10.5 ENO2 SYP
21 cauda equina neoplasm 10.5 ENO2 SYP
22 extraosseous chondrosarcoma 10.5 ENO2 SYP
23 malignant teratoma 10.5 ENO2 SYP
24 odontoma 10.5 KRT18 TUBB3
25 endometrial small cell carcinoma 10.5 ENO2 SYP
26 nodular ganglioneuroblastoma 10.5 ENO2 SYP
27 mucinous ovarian cystadenoma 10.5 ENO2 SYP
28 respiratory system benign neoplasm 10.5 ENO2 SYP
29 angiomyoma 10.5 ENO2 SYP
30 gastric squamous cell carcinoma 10.5 ENO2 SYP
31 gastric small cell carcinoma 10.5 ENO2 SYP
32 desmoplastic small round cell tumor 10.5 ENO2 SYP
33 carcinoid tumors, intestinal 10.5 ENO2 SYP
34 bone benign neoplasm 10.5 ENO2 SYP
35 meningeal melanomatosis 10.5 ENO2 SYP
36 extraskeletal ewing sarcoma 10.5 ENO2 SYP
37 embryoma 10.4 DICER1 SYP
38 connective tissue benign neoplasm 10.4 ENO2 SYP
39 glomus tumor 10.4 ENO2 SYP
40 intraocular retinoblastoma 10.4 ENO2 SYP
41 sclerosing hemangioma 10.4 ENO2 SYP
42 mixed cell type cancer 10.4 ENO2 SYP
43 carcinoid syndrome 10.4 ENO2 SYP
44 seminal vesicle tumor 10.4 KRT18 SYP
45 ovarian mucinous neoplasm 10.4 ENO2 SYP
46 cervix small cell carcinoma 10.4 ENO2 SYP
47 olfactory neuroblastoma 10.4 ENO2 SYP
48 basaloid squamous cell carcinoma 10.4 ENO2 SYP
49 cerebral primitive neuroectodermal tumor 10.4 ENO2 SYP
50 horseshoe kidney 10.4 ENO2 SYP

Comorbidity relations with Pineal Gland Cancer via Phenotypic Disease Network (PDN):


Obstructive Hydrocephalus

Graphical network of the top 20 diseases related to Pineal Gland Cancer:



Diseases related to Pineal Gland Cancer

Symptoms & Phenotypes for Pineal Gland Cancer

MGI Mouse Phenotypes related to Pineal Gland Cancer:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 nervous system MP:0003631 9.17 DICER1 ENO2 GFAP PTPRS SAG SYP

Drugs & Therapeutics for Pineal Gland Cancer

Drugs for Pineal Gland Cancer (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 167)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Etoposide Approved Phase 2, Phase 3,Phase 1,Not Applicable 33419-42-0 36462
2
Carboplatin Approved Phase 2, Phase 3,Phase 3,Phase 1,Not Applicable 41575-94-4 10339178 498142 38904
3
Thiotepa Approved, Investigational Phase 2, Phase 3,Not Applicable 52-24-4 5453
4
Cyclophosphamide Approved, Investigational Phase 2, Phase 3,Phase 3,Not Applicable 50-18-0, 6055-19-2 2907
5
Melphalan Approved Phase 2, Phase 3,Phase 1 148-82-3 4053 460612
6
Lenograstim Approved, Investigational Phase 3,Phase 2,Phase 1 135968-09-1
7
Donepezil Approved Phase 3,Phase 2 120014-06-4 3152
8
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
9
Isotretinoin Approved Phase 3,Not Applicable 4759-48-2 5538 5282379
10
Cisplatin Approved Phase 3,Not Applicable 15663-27-1 84093 441203 2767
11
Vincristine Approved, Investigational Phase 3,Not Applicable 2068-78-2, 57-22-7 5978
12 Pancreatic Polypeptide Investigational Phase 3,Phase 1 59763-91-6
13 Dermatologic Agents Phase 3,Phase 2,Phase 1,Not Applicable
14 Etoposide phosphate Phase 2, Phase 3,Phase 1,Not Applicable
15 Analgesics Phase 3,Phase 2,Phase 1
16 Alkylating Agents Phase 3,Phase 2,Phase 1,Not Applicable
17 Central Nervous System Depressants Phase 3,Phase 2
18 Adjuvants, Anesthesia Phase 3
19 Cholinergic Agents Phase 3,Phase 2
20 Cholinesterase Inhibitors Phase 3,Phase 2
21 Narcotics Phase 3
22 Neurotransmitter Agents Phase 3,Phase 2
23 Analgesics, Opioid Phase 3
24 Anesthetics Phase 3
25 Nootropic Agents Phase 3,Phase 2
26 Anesthetics, General Phase 3
27 Anesthetics, Intravenous Phase 3
28 Peripheral Nervous System Agents Phase 3,Phase 2,Phase 1
29 Immunosuppressive Agents Phase 3,Phase 2,Phase 1,Not Applicable
30 Liver Extracts Phase 3,Phase 1,Phase 2
31 Antirheumatic Agents Phase 3,Phase 2,Phase 1,Not Applicable
32 Antimitotic Agents Phase 3,Phase 1,Not Applicable
33 Antineoplastic Agents, Alkylating Phase 3,Phase 2,Phase 1,Not Applicable
34 Antineoplastic Agents, Phytogenic Phase 3,Phase 2,Phase 1,Not Applicable
35 Adjuvants, Immunologic Phase 3,Phase 1
36 Cola Nutraceutical Phase 3,Phase 1
37
Dacarbazine Approved, Investigational Phase 2,Phase 1 4342-03-4 5351166
38
Irinotecan Approved, Investigational Phase 2,Phase 1 97682-44-5, 100286-90-6 60838
39
Temozolomide Approved, Investigational Phase 2,Phase 1 85622-93-1 5394
40
Miconazole Approved, Investigational, Vet_approved Phase 2,Phase 1 22916-47-8 4189
41 Piracetam Approved, Investigational Phase 2 7491-74-9
42
Pregabalin Approved, Illicit, Investigational Phase 2 148553-50-8 5486971
43
Everolimus Approved Phase 2,Phase 1 159351-69-6 6442177
44
Bevacizumab Approved, Investigational Phase 2 216974-75-3
45
Sirolimus Approved, Investigational Phase 2,Phase 1 53123-88-9 5284616 6436030 46835353
46
Dasatinib Approved, Investigational Phase 2,Phase 1 302962-49-8 3062316
47
Ifosfamide Approved Phase 1, Phase 2 3778-73-2 3690
48
Benzocaine Approved, Investigational Phase 2 1994-09-7, 94-09-7 2337
49
Ethanol Approved Phase 2 64-17-5 702
50
Sorbitol Approved Phase 2 50-70-4 5780

Interventional clinical trials:

(show top 50) (show all 63)
# Name Status NCT ID Phase Drugs
1 Stem Cell Transplant for High Risk Central Nervous System (CNS) Tumors Unknown status NCT00179803 Phase 2, Phase 3
2 Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Completed NCT00538850 Phase 3 Fentanyl sublingual spray;Placebo
3 Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors Completed NCT00369785 Phase 3 donepezil hydrochloride;Placebo
4 Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma Recruiting NCT00392327 Phase 3 Vincristine Sulfate;Carboplatin;Cisplatin;Cyclophosphamide;Isotretinoin
5 Study of Fixed vs. Flexible Filgrastim to Accelerate Bone Marrow Recovery After Chemotherapy in Children With Cancer Active, not recruiting NCT01987596 Phase 3
6 Proton Beam Radiation Therapy in Treating Patients With Low Grade Gliomas Unknown status NCT01024907 Phase 1, Phase 2
7 Combination Chemotherapy, Surgery or Radiation Therapy, and Peripheral Stem Cell Transplant in Treating Patients With Recurrent Medulloblastoma or Primitive Neuroectodermal and Pineal Tumors Completed NCT00025077 Phase 2 carboplatin;cyclophosphamide;thiotepa
8 Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer Completed NCT00492089 Phase 2 bevacizumab;placebo
9 Levetiracetam or Pregabalin in Treating Seizures in Patients Undergoing Chemotherapy and/or Radiation Therapy For Primary Brain Tumors Completed NCT00629889 Phase 2 levetiracetam;pregabalin
10 Phase II Studies Of Donepezil And Ginkgo Biloba In Irradiated Brain Tumor Completed NCT00070161 Phase 2 donepezil hydrochloride
11 Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Tumors Completed NCT00003461 Phase 1, Phase 2
12 Prospective Pilot Trial to Assess a Multimodal Molecular Targeted Therapy in Children, Adolescent and Young Adults With Relapsed or Refractory High-grade Pineoblastoma Recruiting NCT02596828 Phase 2 Temozolomide;Irinotecan;Dasatinib;Rapamycin
13 Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors Active, not recruiting NCT01217437 Phase 2 Irinotecan Hydrochloride;Temozolomide
14 Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors Active, not recruiting NCT00788125 Phase 1, Phase 2 carboplatin;dasatinib;etoposide phosphate;ifosfamide
15 Plerixafor After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed High Grade Glioma Active, not recruiting NCT01977677 Phase 1, Phase 2 temozolomide;plerixafor
16 Melphalan, Carboplatin, Mannitol, and Sodium Thiosulfate in Treating Patients With Recurrent or Progressive CNS Embryonal or Germ Cell Tumors Suspended NCT00983398 Phase 1, Phase 2 Carboplatin;Mannitol;Melphalan;Sodium Thiosulfate
17 Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors Unknown status NCT00002647 Phase 1 verteporfin
18 Stereotactic Radiosurgery in Treating Patients With Brain Tumors Completed NCT00019578 Phase 1
19 RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma Completed NCT01119599 Phase 1 Gamma-Secretase Inhibitor RO4929097;Temozolomide
20 Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors Completed NCT00019630 Phase 1 doxorubicin HCl liposome
21 A Feasibility, Dose-Escalation Study Using Intracerebral Microdialysis to Assess the Neuropharmacodynamics of Temsirolimus in Patients With Primary or Metastatic Brain Tumors Completed NCT00784914 Phase 1 temsirolimus
22 Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to Treatment Completed NCT00544284 Phase 1 bortezomib;temozolomide
23 Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer Completed NCT00006368 Phase 1
24 Calcitriol Plus Carboplatin in Treating Patients With Advanced Solid Tumors Completed NCT00008086 Phase 1 carboplatin
25 Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma Completed NCT01273090 Phase 1 imetelstat sodium
26 Thalidomide and Docetaxel in Treating Patients With Advanced Cancer Completed NCT00049296 Phase 1 docetaxel;thalidomide
27 Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas Completed NCT00019019 Phase 1 carboxyamidotriazole;paclitaxel
28 PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System Tumors Completed NCT01158300 Phase 1 VEGF inhibitor PTC299
29 Radiolabeled Monoclonal Antibody Therapy After Radiation Therapy in Treating Patients With Primary Brain Tumors Completed NCT00003484 Phase 1 carmustine;irinotecan hydrochloride
30 MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma Completed NCT00020579 Phase 1 entinostat
31 Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors Completed NCT01076530 Phase 1 vorinostat;temozolomide
32 Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma Completed NCT00994500 Phase 1 vorinostat;bortezomib
33 ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors Completed NCT00946335 Phase 1 veliparib;temozolomide
34 AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors Completed NCT00326664 Phase 1 Cediranib Maleate
35 Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors Completed NCT00100880 Phase 1 lenalidomide
36 Cilengitide in Treating Children With Refractory Primary Brain Tumors Completed NCT00063973 Phase 1 cilengitide
37 Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors Completed NCT00052780 Phase 1 O6-benzylguanine;temozolomide
38 SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors Recruiting NCT03434262 Phase 1 Gemcitabine;ribociclib;sonidegib;trametinib
39 Entinostat in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors Recruiting NCT02780804 Phase 1 Entinostat
40 Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors Recruiting NCT02255461 Phase 1 palbociclib isethionate
41 Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor Active, not recruiting NCT00638898 Phase 1 busulfan;melphalan;topotecan hydrochloride
42 Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors Terminated NCT00110032 Phase 1 EF5
43 Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia Terminated NCT01088763 Phase 1 gamma-secretase/Notch signalling pathway inhibitor RO4929097;dexamethasone
44 A Phase I Study of IMC-A12 in Combination With Temsirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors Withdrawn NCT01182883 Phase 1 IMC-A12;Temsirolimus
45 Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom Unknown status NCT00757614
46 Morphological Analysis of the Pineal Gland in Pediatric Retinoblastoma Patients Using Magnetic Resonance Imaging Completed NCT01884194
47 Study of Blood and Cheek Cell Samples From Patients With Glioma Completed NCT01009307
48 Study of Tissue Samples From Patients With Glioma or Other Brain Tumors Completed NCT00967200
49 Changes in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed, Progressive, or Recurrent Primary Malignant Brain Tumors Completed NCT00499798
50 Acute Side Effects in Patients Who Are Undergoing Stereotactic Radiosurgery for Brain Tumors or Other Brain Disorders Completed NCT00255671

Search NIH Clinical Center for Pineal Gland Cancer

Genetic Tests for Pineal Gland Cancer

Anatomical Context for Pineal Gland Cancer

The Foundational Model of Anatomy Ontology organs/tissues related to Pineal Gland Cancer:

19
The Pineal Gl

MalaCards organs/tissues related to Pineal Gland Cancer:

41
Pineal, Brain, Bone, Endothelial, T Cells, Spinal Cord, Bone Marrow

Publications for Pineal Gland Cancer

Articles related to Pineal Gland Cancer:

(show all 48)
# Title Authors Year
1
Papillary tumor of the pineal region: Case report and review of the literature. ( 29691144 )
2018
2
Papillary tumor of the pineal region in children: presentation of a case and comprehensive literature review. ( 29906576 )
2018
3
Nuclear CRX and FOXJ1 Expression Differentiates Non-Germ Cell Pineal Region Tumors and Supports the Ependymal Differentiation of Papillary Tumor of the Pineal Region. ( 28719464 )
2017
4
Papillary Tumor of the Pineal Region: A Distinct Molecular Entity. ( 26113311 )
2016
5
Late dissemination via cerebrospinal fluid of papillary tumor of the pineal region: a case report and literature review. ( 27179224 )
2016
6
Increased VEGF levels in one case of papillary tumor of the pineal region with intracranial haemorrhage at presentation: a potential surrogate indicator of tumor angiogenesis and aggressiveness? ( 26745494 )
2016
7
Cytologic features of papillary tumor of the pineal region: A case report showing tigroid background. ( 27535020 )
2016
8
A case of papillary tumor of the pineal region with a long clinical history: molecular characterization and therapeutic consideration with review of the literature. ( 27472995 )
2016
9
Atypical Teratoid/Rhabdoid Tumor of the Pineal Region in a Young Adult Male Patient: Case Report and Review of the Literature. ( 27144539 )
2016
10
Long-term follow-up of a papillary tumor of the pineal region: addendum to a case report. ( 27568037 )
2016
11
Papillary tumor of the pineal region with extended clinical and radiologic follow-up. ( 26539320 )
2015
12
Lack of BRAF-V600E Mutation in Papillary Tumor of the Pineal Region. ( 26125673 )
2015
13
Papillary tumor of the pineal region-report of three cases with literature review. ( 26238893 )
2015
14
Papillary tumor of the pineal region presenting with Foster Kennedy sign. ( 26183673 )
2015
15
Papillary tumor of the pineal region: A case report and review of the literature. ( 26622493 )
2015
16
Papillary tumor of the pineal region: Histopathological characterization and review of the literature. ( 24556386 )
2015
17
Papillary tumor of the pineal region with synchronous suprasellar focus and novel cytogenetic features. ( 26068071 )
2015
18
Outcomes After Surgery and Radiotherapy for Papillary Tumor of the Pineal Region. ( 25749579 )
2015
19
Papillary Tumor of the Pineal Region: MR Signal Intensity Correlated to Histopathology. ( 25688307 )
2015
20
Is CRX protein a useful marker in differential diagnosis of tumors of the pineal region? ( 24555912 )
2014
21
Papillary tumor of the pineal region. Report of two cases and literature review. ( 25440015 )
2014
22
PTEN mutations and activation of the PI3K/Akt/mTOR signaling pathway in papillary tumors of the pineal region. ( 25003235 )
2014
23
Stereotactic radiosurgery of a papillary tumor of the pineal region: case report and review of the literature. ( 23446182 )
2013
24
Bevacizumab is Effective for Recurrent Papillary Tumor of the Pineal Region: First Report. ( 24019784 )
2013
25
CRX/OTX3: a useful marker in the differential diagnosis of tumors of the pineal region and indicator of photoreceptor differentiation in medulloblastomas and atypical teratoid rhabdoid tumors. ( 23235340 )
2013
26
Papillary tumor of the pineal region with anaplastic small cell component. ( 23817812 )
2013
27
Early treatment response of a rare papillary tumor of the pineal region after primary proton-beam therapy using the raster-scanning technique at HIT. ( 23235766 )
2012
28
Histopathologic and ultrastructural features and claudin expression in papillary tumors of the pineal region: a multicenter analysis. ( 22588068 )
2012
29
Atypical teratoid/rhabdoid tumor of the pineal region in an adult. ( 19911885 )
2010
30
Clinicopathological features from long-term observation of a papillary tumor of the pineal region (PTPR): a case report. ( 19856220 )
2009
31
Papillary tumor of the pineal region--a recently described entity: a report of three cases and review of the literature. ( 19642509 )
2009
32
Papillary tumor of the pineal region: a case report. ( 18987834 )
2008
33
Microarray analysis reveals differential gene expression patterns in tumors of the pineal region. ( 16825954 )
2006
34
Prognosis and histopathologic features in papillary tumors of the pineal region: a retrospective multicenter study of 31 cases. ( 17021405 )
2006
35
Papillary neuroepithelial tumor of the pineal region. A case report. ( 15221340 )
2004
36
Pathology case of the month. Tumor of the pineal region. Pineoblastoma, recurrent. ( 15233382 )
2004
37
Papillary tumor of the pineal region. ( 12657936 )
2003
38
Constitutional t(16;22)(p13.3;q11.2 approximately 12) in a primitive neuroectodermal tumor of the pineal region. ( 12660038 )
2003
39
Successful multidisciplinary treatment of an endodermal sinus tumor of the pineal region. ( 8870440 )
1996
40
Treatment of nongerminomatous germ-cell tumors of the pineal region. ( 7514765 )
1994
41
Mixed germ-cell tumor of the pineal region. Case report. ( 2433417 )
1987
42
Endodermal sinus tumor of the pineal region presenting with a radicular pain. ( 2947803 )
1986
43
Endodermal sinus tumor of the pineal region. Metastases through a ventriculoperitoneal shunt. ( 6744218 )
1984
44
Peritoneal implantation of endodermal sinus tumor of the pineal region via a ventriculoperitoneal shunt. Cytodiagnosis with immunocytochemical demonstration of alpha-fetoprotein. ( 6199934 )
1984
45
Endodermal sinus tumor of the pineal region. ( 7378998 )
1980
46
Endodermal sinus tumor of the pineal region: case report and review of literature. ( 383267 )
1979
47
Endodermal sinus tumor of the pineal region: case report. ( 84363 )
1978
48
Endodermal sinus tumor of the pineal region: case report. ( 1000478 )
1976

Variations for Pineal Gland Cancer

Expression for Pineal Gland Cancer

Search GEO for disease gene expression data for Pineal Gland Cancer.

Pathways for Pineal Gland Cancer

Pathways related to Pineal Gland Cancer according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 11.56 ENO2 GFAP SAG SYP TUBB3
2
Show member pathways
11.17 GFAP KRT18 TUBB3

GO Terms for Pineal Gland Cancer

Cellular components related to Pineal Gland Cancer according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 axon GO:0030424 9.33 DICER1 PTPRS TUBB3
2 photoreceptor inner segment GO:0001917 8.96 ENO2 SAG
3 integral component of synaptic vesicle membrane GO:0030285 8.62 PTPRS SYP

Sources for Pineal Gland Cancer

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....